
Research Solutions Inc. (NASDAQ:RSSS – Free Report) – Research analysts at Maxim Group issued their Q1 2027 earnings estimates for shares of Research Solutions in a report issued on Thursday, September 10th. Maxim Group analyst A. Klee anticipates that the company will post earnings per share of $0.02 for the quarter. The consensus estimate for Research Solutions’ current full-year earnings is $0.12 per share. Maxim Group also issued estimates for Research Solutions’ Q2 2027 earnings at $0.02 EPS, Q3 2027 earnings at $0.02 EPS, Q4 2027 earnings at $0.03 EPS, FY2027 earnings at $0.10 EPS, Q1 2028 earnings at $0.02 EPS, Q2 2028 earnings at $0.02 EPS, Q3 2028 earnings at $0.02 EPS, Q4 2028 earnings at $0.03 EPS and FY2028 earnings at $0.11 EPS.
Several other analysts have also issued reports on RSSS. Lake Street Capital reduced their price objective on shares of Research Solutions from $5.00 to $4.00 and set a “buy” rating on the stock in a report on Monday, May 18th. Weiss Ratings reissued a “hold (c-)” rating on shares of Research Solutions in a research note on Wednesday, August 12th. Three investment analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, Research Solutions presently has an average rating of “Moderate Buy” and a consensus target price of $3.83.
Research Solutions Stock Down 7.5%
NASDAQ:RSSS opened at $1.98 on Tuesday. Research Solutions has a 52 week low of $1.96 and a 52 week high of $4.12. The stock’s fifty day moving average is $2.22 and its two-hundred day moving average is $2.30. The company has a market capitalization of $66.23 million, a P/E ratio of 22.00 and a beta of 0.75.
Research Solutions (NASDAQ:RSSS – Get Free Report) last released its quarterly earnings data on Wednesday, September 9th. The company reported $0.02 EPS for the quarter, missing analysts’ consensus estimates of $0.04 by ($0.02). The business had revenue of $12.08 million during the quarter, compared to analyst estimates of $11.95 million. Research Solutions had a net margin of 5.84% and a return on equity of 16.32%.
Institutional Inflows and Outflows
Several hedge funds and other institutional investors have recently made changes to their positions in the business. Punch & Associates Investment Management Inc. acquired a new position in shares of Research Solutions in the second quarter valued at approximately $5,922,000. Bard Associates Inc. acquired a new stake in Research Solutions during the 2nd quarter worth approximately $1,413,000. North Star Investment Management Corp. purchased a new position in Research Solutions in the 1st quarter valued at approximately $754,000. Navalign LLC boosted its position in Research Solutions by 154.7% in the 1st quarter. Navalign LLC now owns 251,126 shares of the company’s stock valued at $568,000 after buying an additional 152,546 shares during the period. Finally, BlackRock Inc. acquired a new position in shares of Research Solutions in the second quarter worth $332,000. Hedge funds and other institutional investors own 33.60% of the company’s stock.
Trending Headlines about Research Solutions
Here are the key news stories impacting Research Solutions this week:
- Neutral Sentiment: Maxim Group expects Research Solutions to earn approximately $0.02 per share in each quarter of 2027, with fourth-quarter EPS rising to $0.03. The firm projects full-year 2027 EPS of $0.10 and 2028 EPS of $0.11. Research Solutions analyst estimates
- Negative Sentiment: The $0.10 2027 and $0.11 2028 forecasts are below the company’s current full-year consensus estimate of $0.12, suggesting analysts expect relatively modest earnings growth and potentially limiting investor enthusiasm.
- Negative Sentiment: RSSS opened at $1.98, close to its one-year low of $1.96 and below its 50-day and 200-day moving averages of $2.22 and $2.30, respectively. That weak technical positioning may amplify selling pressure when there is no major positive catalyst.
Research Solutions Company Profile
Research Solutions, Inc (NASDAQ:RSSS) is a provider of software and managed services that streamline access to and management of scientific, technical and medical research. The company’s flagship platform automates the acquisition, licensing and delivery of journal articles, conference proceedings and other pay-walled content, enabling institutions to reduce administrative overhead and control subscription costs.
Key offerings include self-service workflows for document requests, enterprise-grade managed services for high-volume users, and analytics tools that deliver detailed reporting on spend, usage patterns and supplier performance.
See Also
- Five stocks we like better than Research Solutions
- 3 Defense Stocks Riding the High-Energy Laser Boom
- Analysts Are Punting Their Calls Into the Next Quarter After Adobe’s Mixed Earnings
- Institutional Money Is Pouring Into These 2 Altcoin ETFs
- The End of Big Tech Buybacks? Only One Hyperscaler Is Still Repurchasing Shares
Receive News & Ratings for Research Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Research Solutions and related companies with MarketBeat.com's FREE daily email newsletter.
